The Department of Health and Human Services has withdrawn an earlier notice from the FDA about fee rates under the Over-the-Counter Monograph Drug User Fee Program for 2021. This withdrawal is due to the lack of delegated authority for the FDA to issue the notice. Consequently, the FDA has stopped all efforts to collect fees for this program until new instructions are announced. The original notice, part of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), was published on December 29, 2020, and is officially withdrawn as of January 6, 2021.
Simple Explanation
The government is saying that the FDA tried to make people pay fees for certain medicines, but it turns out they weren't allowed to do that, so now they have to stop until they figure things out.